The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
how is it going to be distributed probably at least in part in like large chain pharmacies are the pharmacists going to be as good at doing what was done during the trial because certainly as you said at the beginning i mean these are mrna is labile and if it degrades and it certainly has the capacity to degrade will we get less efficacy effectiveness of the vaccine in a real world situation than we did in a experimental situation
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.